Cancer Treatment Denied in California: Appeal Guide

A cancer diagnosis is devastating enough without the added burden of an insurance denial. In California, patients facing refused coverage for chemotherapy, immunotherapy, clinical trials, or reconstructive surgery have powerful legal protections and a clear path to fight back. This guide explains what you need to know about California's insurance landscape, common denial reasons, and how to build a winning appeal.

California's Insurance Landscape for Cancer Patients

California is home to some of the largest health insurers in the country. Anthem Blue Cross, Blue Shield of California, Kaiser Permanente, Health Net, and Covered California exchange plans all operate across the state. Medi-Cal — California's Medicaid program — provides coverage to low-income Californians and has specific cancer treatment provisions under the Medi-Cal Cancer Treatment Program.

The California Department of Managed Health Care (DMHC) regulates HMO plans, while the California Department of Insurance (CDI) oversees PPO and indemnity products. Knowing which agency governs your plan is essential before filing any complaint or External Independent Review: Complete Guide" class="auto-link">external review request.

State Protections for Cancer Patients

California has enacted some of the most comprehensive patient protections in the nation.

Clinical Trial Mandate: Under California Health and Safety Code Section 1370.6, fully insured HMO and PPO plans must cover routine patient costs associated with qualifying cancer clinical trials. This includes office visits, labs, imaging, and supportive care — not just the experimental treatment itself. If your insurer denied costs tied to a clinical trial, cite this statute in your appeal.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior Authorization Limits: California's SB 1196 and related regulations restrict how insurers can use prior authorization for cancer drugs. Step therapy (requiring cheaper drugs before approving the prescribed one) is limited for cancer patients, and exceptions must be granted when a treating oncologist documents medical necessity.

External Review Rights: California residents have the right to an Independent Medical Review (IMR) through the DMHC or CDI. For urgent cancer cases, expedited IMR decisions must be issued within 72 hours. Historically, cancer-related IMR overturns occur at high rates in California, making external review a powerful tool.

Anti-Cancer Parity Law: California requires that oral cancer drugs be covered at the same cost-sharing level as intravenous cancer drugs administered in a clinical setting.

Common Denial Reasons in California

Cancer patients across California frequently encounter these denial types:

• Immunotherapy denials: Drugs like pembrolizumab (Keytruda) or nivolumab (Opdivo) are denied as "experimental" or outside approved indications, even when supported by oncologist documentation.
• Targeted therapy refusals: Insurers may deny EGFR inhibitors, ALK inhibitors, or PARP inhibitors pending prior authorization or step therapy compliance.
• Proton therapy denials: Despite clinical evidence, proton beam therapy is often flagged as "investigational" for certain cancer types.
• Genetic testing denials: BRCA1/2, BRCA-related gene panel testing, and tumor genomic profiling (e.g., Foundation One) are frequently denied as not medically necessary.
• Reconstructive surgery: Post-mastectomy reconstruction is mandated under the Women's Health and Cancer Rights Act (WHCRA), yet some insurers attempt to limit or delay this coverage.

How to Appeal a Cancer Denial in California

Step 1 — Internal Appeal: Submit a written internal appeal within your plan's deadline (typically 180 days for non-urgent cases). Include your oncologist's letter of medical necessity, peer-reviewed literature supporting the treatment, NCCN (National Comprehensive Cancer Network) guidelines, and any clinical trial eligibility documentation.

Step 2 — Expedited Review: If your condition is life-threatening or your health could deteriorate without the treatment, request an expedited internal review. California law requires a decision within 72 hours for urgent cases.

Step 3 — IMR or External Review: After exhausting internal appeal, file for an IMR with the DMHC (for HMO plans) or CDI (for PPO plans). The filing fee is minimal. An independent physician reviews your case, and the insurer must abide by the decision.

Step 4 — DMHC Help Center: The DMHC Help Center (1-888-466-2219) can intervene in urgent cases and has authority to require expedited reviews.

State and Community Resources

• Medi-Cal Cancer Treatment Program: Covers cancer treatment for eligible low-income Californians who otherwise lack coverage.
• California Cancer Coalition: Tracks state cancer policy and provides patient navigation resources.
• American Cancer Society (ACS) Helpline: 1-800-227-2345, available 24/7 for cancer patients needing help navigating insurance issues, transportation, and support services.
• Patient Advocate Foundation: Offers case managers who can help California cancer patients navigate insurer disputes.

Key Laws to Cite in Your Appeal

• California Health and Safety Code § 1370.6 (clinical trial coverage)
• California Insurance Code § 10112.27 (oral chemotherapy parity)
• California Health and Safety Code § 1374.183 (step therapy exceptions)
• Women's Health and Cancer Rights Act (federal)
• Americans with Disabilities Act (ADA) if denial constitutes disability discrimination

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal